We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Shenzhen YHLO Biotech Co., Ltd.

Shenzhen YHLO Biotech Co., Ltd. (YHLO) is an immunoassay solutions company that specializes in developing, manufactur... read more Featured Products: More products

Download Mobile App





YHLO Unveils New iBC 900 Automated Chemistry Analyzer

By LabMedica International staff writers
Posted on 07 Feb 2024

YHLO (Shenzhen, China) is unveiling its latest innovations and breakthroughs in IVD at Medlab Middle East in Dubai, taking place February 5-8, 2024. More...

YHLO is launching the new iBC 900 automated chemistry analyzer which offers multidirectional modular expansion and compatibility with iFlash 3000, making it a game-changer for medical laboratories worldwide. At Medlab Middle East 2024, YHLO is showcasing its iFlash series of chemiluminescence immunoassay analyzers, including the iFlash 1200, iFlash 1800, and iFlash 3000. iFlash 1200 is the latest addition to the iFlash family, offering an unparalleled workstation to low-mid volume testing laboratories, especially with limited floor space. On the other hand, iFlash 1800 offers better efficiency and reliability with fewer outsourced samples, improved in-house controlled quality, and higher throughput. The iFlash 3000 chemiluminescence immunoassay analyzer is designed not only to meet the fundamental needs of large laboratories, but also to improve their efficiency, productivity, and quality.

In addition, YHLO is highlighting the VISION ESR analyzer that redefines the analysis of Erythrocyte Sedimentation Rate (ESR). The ESR is a nonspecific indicator of inflammation in the body. When there is inflammation or infection present, certain proteins in the blood cause red blood cells to stick together and settle more rapidly. By measuring the rate at which red blood cells settle, the VISION ESR analyzer provides valuable information about the inflammatory response, aiding in the diagnosis and monitoring of various conditions. It provides a real ESR curve and Bio-Rad control assigned value and delivers results in 20 minutes with excellent Westergren correlation. It uses primary EDTA tubes and offers batch and STAT test modes with a state-of-the-art design for the least maintenance.

Related Links:
YHLO


Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gold Member
Hybrid Pipette
SWITCH
Gel Cards
DG Gel Cards
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Original illustration showing how exposure-linked mutation patterns may influence tumor immune visibility (Photo courtesy of Máté Manczinger, HUN-REN Szeged BRC)

Cancer Mutation ‘Fingerprints’ to Improve Prediction of Immunotherapy Response

Cancer cells accumulate thousands of genetic mutations, but not all mutations affect tumors in the same way. Some make cancer cells more visible to the immune system, while others allow tumors to evade... Read more

Industry

view channel
Image: The partnership with LLS expands access to Lucent’s non-invasive blood-based biomarker tests for early detection of cognitive diseases (photo courtesy of Adobe Stock)

New Partnership Brings Alzheimer’s Blood Biomarker Test to Community Screening Network

Lucent Diagnostics, a brand of Quanterix Corporation, has partnered with Life Line Screening (LLS) to offer Lucent’s non‑invasive, blood‑based biomarker test across the United States. Programs are... Read more
MEDLAB 2024
Copyright © 2000-2026 Globetech Media. All rights reserved.